- Home
- CLRB vs NXPL Comparison
CLRB vs NXPL Comparison
Compare CLRB & NXPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLRB
- NXPL
- Stock Information
- Founded
- CLRB 2002
- NXPL 1997
- Country
- CLRB United States
- NXPL United States
- Employees
- CLRB N/A
- NXPL N/A
- Industry
- CLRB Biotechnology: Pharmaceutical Preparations
- NXPL Telecommunications Equipment
- Sector
- CLRB Health Care
- NXPL Telecommunications
- Exchange
- CLRB Nasdaq
- NXPL Nasdaq
- Market Cap
- CLRB 17.6M
- NXPL 17.9M
- IPO Year
- CLRB N/A
- NXPL N/A
- Fundamental
- Price
- CLRB $4.98
- NXPL $0.77
- Analyst Decision
- CLRB Hold
- NXPL
- Analyst Count
- CLRB 2
- NXPL 0
- Target Price
- CLRB N/A
- NXPL N/A
- AVG Volume (30 Days)
- CLRB 1.3M
- NXPL 29.3K
- Earning Date
- CLRB 08-12-2025
- NXPL 08-13-2025
- Dividend Yield
- CLRB N/A
- NXPL N/A
- EPS Growth
- CLRB N/A
- NXPL N/A
- EPS
- CLRB N/A
- NXPL N/A
- Revenue
- CLRB N/A
- NXPL $62,515,000.00
- Revenue This Year
- CLRB N/A
- NXPL N/A
- Revenue Next Year
- CLRB N/A
- NXPL N/A
- P/E Ratio
- CLRB N/A
- NXPL N/A
- Revenue Growth
- CLRB N/A
- NXPL 19.36
- 52 Week Low
- CLRB $4.36
- NXPL $0.43
- 52 Week High
- CLRB $94.50
- NXPL $2.30
- Technical
- Relative Strength Index (RSI)
- CLRB 33.34
- NXPL 65.14
- Support Level
- CLRB $6.50
- NXPL $0.68
- Resistance Level
- CLRB $8.30
- NXPL $0.75
- Average True Range (ATR)
- CLRB 1.42
- NXPL 0.07
- MACD
- CLRB -0.66
- NXPL 0.00
- Stochastic Oscillator
- CLRB 1.63
- NXPL 67.05
About CLRB Cellectar Biosciences Inc.
Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage a proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. It has one operating and reportable segment focused on utilizing its PDC platform to develop drugs for the treatment of cancer.
About NXPL NextPlat Corp
NextPlat Corp is an e-commerce and healthcare company. Its e-commerce venues form an effective network serving thousands of consumers, enterprises, and governments. Its healthcare business is focused on improving the lives of patients with complex chronic diseases through patient and provider engagement and their partnerships with payors, pharmaceutical manufacturers, and distributors, offering a broad range of solutions to address the dispensing, delivery, dosing, and reimbursement of clinically intensive, high-cost drugs. The company operates in two segments: e-Commerce Operations involves acquiring and leasing an e-commerce platform; and Healthcare Operations provides TPA, data management, COVID-19 related diagnostics and vaccinations, prescription pharmaceuticals, and Others.